Literature DB >> 16796358

Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics.

Mutasem M Rawas-Qalaji1, F Estelle R Simons, Keith J Simons.   

Abstract

The aim of this study was to evaluate the effect of increasing epinephrine load on the characteristics of fast-disintegrating sublingual tablets for the potential emergency treatment of anaphylaxis. Four tablet formulations, A, B, C, and D, containing 0%, 6%, 12%, and 24% of epinephrine bitartrate, respectively, and microcrystalline cellulose:low-substituted hydroxypropyl cellulose (9:1), were prepared by direct compression, at a range of compression forces. Tablet weight variation, content uniformity, hardness, disintegration time, wetting time, and friability were measured for each formulation at each compression force. All 4 tablet formulations at each compression force were within the United States Pharmacopeia (USP) limits for weight variation and content uniformity. A linear increase in compression force resulted in an exponential increase in hardness for all formulations, a linear increase in disintegration and wetting times of A, and an exponential increase in disintegration and wetting times of B, C, and D. At a mean +/- SD hardness of > or = 2.3 +/- 0.2 kg, all tablet formulations passed the USP friability test. At a mean +/- SD hardness of < or = 3.1 +/- 0.2 kg, all tablet formulations resulted in disintegration and wetting times of <10 seconds and <30 seconds, respectively. Tablets with drug loads from 0% to 24% epinephrine can be formulated with hardness, disintegration times, and wetting times suitable for sublingual administration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16796358      PMCID: PMC2750292          DOI: 10.1208/pt070241

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  18 in total

1.  Characterisation of instantaneous water absorption properties of pharmaceutical excipients.

Authors:  P Hedenus; M Strømme Mattsson; G A Niklasson; O Camber; R Ek
Journal:  Int J Pharm       Date:  2000-07-20       Impact factor: 5.875

2.  Fast dispersible ibuprofen tablets.

Authors:  Simone Schiermeier; Peter Christian Schmidt
Journal:  Eur J Pharm Sci       Date:  2002-04       Impact factor: 4.384

3.  Evaluation of disintegration testing of different fast dissolving tablets using the texture analyzer.

Authors:  Silvia Kocova el-Arini; Sophie-Dorothée Clas
Journal:  Pharm Dev Technol       Date:  2002       Impact factor: 3.133

Review 4.  First-aid treatment of anaphylaxis to food: focus on epinephrine.

Authors:  F Estelle R Simons
Journal:  J Allergy Clin Immunol       Date:  2004-05       Impact factor: 10.793

5.  Preparation of rapidly disintegrating tablet using new types of microcrystalline cellulose (PH-M series) and low substituted-hydroxypropylcellulose or spherical sugar granules by direct compression method.

Authors:  T Ishikawa; B Mukai; S Shiraishi; N Utoguchi; M Fujii; M Matsumoto; Y Watanabe
Journal:  Chem Pharm Bull (Tokyo)       Date:  2001-02       Impact factor: 1.645

6.  Pharmacokinetics of acetaminophen from rapidly disintegrating compressed tablet prepared using microcrystalline cellulose (PH-M-06) and spherical sugar granules.

Authors:  T Ishikawa; N Koizumi; B Mukai; N Utoguchi; M Fujii; M Matsumoto; H Endo; S Shirotake; Y Watanabe
Journal:  Chem Pharm Bull (Tokyo)       Date:  2001-02       Impact factor: 1.645

7.  The preparation of rapidly disintegrating tablets in the mouth.

Authors:  M Sugimoto; K Matsubara; Y Koida; M Kobayashi
Journal:  Pharm Dev Technol       Date:  2001-11       Impact factor: 3.133

Review 8.  Use of epinephrine in the treatment of anaphylaxis.

Authors:  Phil Lieberman
Journal:  Curr Opin Allergy Clin Immunol       Date:  2003-08

9.  New compressed tablet rapidly disintegrating in saliva in the mouth using crystalline cellulose and a disintegrant.

Authors:  Y Watanabe; K Koizumi; Y Zama; M Kiriyama; Y Matsumoto; M Matsumoto
Journal:  Biol Pharm Bull       Date:  1995-09       Impact factor: 2.233

10.  Sublingual epinephrine tablets versus intramuscular injection of epinephrine: dose equivalence for potential treatment of anaphylaxis.

Authors:  Mutasem M Rawas-Qalaji; F Estelle R Simons; Keith J Simons
Journal:  J Allergy Clin Immunol       Date:  2006-02       Impact factor: 10.793

View more
  13 in total

1.  Formulation of a novel tianeptine sodium orodispersible film.

Authors:  Doaa Ahmed El-Setouhy; Nevine Shawky Abd El-Malak; Nevine Shawky Abd El-Malak
Journal:  AAPS PharmSciTech       Date:  2010-06-08       Impact factor: 3.246

2.  An electronic tongue: evaluation of the masking efficacy of sweetening and/or flavoring agents on the bitter taste of epinephrine.

Authors:  Ousama Rachid; F Estelle R Simons; Mutasem Rawas-Qalaji; Keith J Simons
Journal:  AAPS PharmSciTech       Date:  2010-03-30       Impact factor: 3.246

3.  Dissolution testing of sublingual tablets: a novel in vitro method.

Authors:  Ousama Rachid; Mutasem Rawas-Qalaji; F Estelle R Simons; Keith J Simons
Journal:  AAPS PharmSciTech       Date:  2011-04-27       Impact factor: 3.246

4.  Dissolution improvement of electrospun nanofiber-based solid dispersions for acetaminophen.

Authors:  Deng-Guang Yu; Christopher Branford-White; Kenneth White; Xue-Lian Li; Li-Min Zhu
Journal:  AAPS PharmSciTech       Date:  2010-05-06       Impact factor: 3.246

5.  Simplifying influenza vaccination during pandemics: sublingual priming and intramuscular boosting of immune responses with heterologous whole inactivated influenza vaccine.

Authors:  Senthil Murugappan; Harshad P Patil; Henderik W Frijlink; Anke Huckriede; Wouter L J Hinrichs
Journal:  AAPS J       Date:  2014-01-31       Impact factor: 4.009

6.  Sublingual Diffusion of Epinephrine Microcrystals from Rapidly Disintegrating Tablets for the Potential First-Aid Treatment of Anaphylaxis: In Vitro and Ex Vivo Study.

Authors:  Mutasem M Rawas-Qalaji; Shima Werdy; Ousama Rachid; F Estelle R Simons; Keith J Simons
Journal:  AAPS PharmSciTech       Date:  2015-03-04       Impact factor: 3.246

7.  Formulation and evaluation of bi-layer tablet of metoclopramide hydrochloride and ibuprofen.

Authors:  Bhavesh Shiyani; Surendra Gattani; Sanjay Surana
Journal:  AAPS PharmSciTech       Date:  2008-07-09       Impact factor: 3.246

8.  Characterization and in vivo efficacy of a heptapeptide ODT formulation for the treatment of neurogenic bladder dysfunction.

Authors:  Jungeun Bae; Thomas A Johnston; Rungsiri Chaiittianan; Khaetthareeya Sutthanut; Michael Jay; Lesley Marson
Journal:  Int J Pharm       Date:  2017-11-28       Impact factor: 5.875

9.  Preparation and evaluation of orally disintegrating tablets containing taste-masked microcapsules of berberine hydrochloride.

Authors:  Xuelian Hu; Yingbo Li; Engjuan Zhang; Xianzhu Wang; Mao Xing; Qian Wang; Jian Lei; Hua Huang
Journal:  AAPS PharmSciTech       Date:  2012-11-22       Impact factor: 3.246

10.  Scalable flibanserin nanocrystal-based novel sublingual platform for female hypoactive sexual desire disorder: engineering, optimization adopting the desirability function approach and in vivo pharmacokinetic study.

Authors:  Marianne J Naguib; Amal I A Makhlouf
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.